Ratings by BTIG (Mark A. Massaro)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2026 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Sell (N/A) |
|
Details | ||
| 8/25/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Sell (N/A) |
|
Details | ||
| 8/23/2024 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Sell (N/A) |
|
Details | ||
| 8/13/2024 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Sell (N/A) |
|
Details | ||
| 6/26/2024 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Sell (N/A) |
|
Details | ||
| 5/15/2024 | Ginkgo Bioworks Holdings Inc | DNA | Downgrade | Sell (Neutral) |
0.86 (8.86) |
930.23% | Details | |
| 3/14/2024 | Cue Health Inc | HLTH | Downgrade | Neutral (Buy) |
0.29 (0.04) |
-86.21% | Details | |
| 11/9/2023 | Ginkgo Bioworks Holdings Inc | DNA | Downgrade | Neutral (Buy) |
1.49 (0.86) |
-42.28% | Details | |
| 8/16/2023 | Talis Biomedical Corp. | TLIS | Maintain | Sell (N/A) |
|
Details | ||
| 5/17/2023 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Cue Health Inc | HLTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Cue Health Inc | HLTH | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2022 | OncoCyte Corp | OCX | Downgrade | Neutral (Buy) |
0.47 (3.20) |
580.85% | Details | |
| 11/16/2022 | Talis Biomedical Corp. | TLIS | Maintain | Sell (N/A) |
|
Details | ||
| 11/10/2022 | Cue Health Inc | HLTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2022 | Cue Health Inc | HLTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Talis Biomedical Corp. | TLIS | Maintain | Sell (N/A) |
|
Details | ||
| 5/18/2022 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Cue Health Inc | HLTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2022 | Talis Biomedical Corp. | TLIS | Downgrade | Sell (Neutral) |
1.42 (4.38) |
208.45% | Details | |
| 3/11/2022 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2022 | Ginkgo Bioworks Holdings Inc | DNA | New Coverage | Buy (N/A) |
6.99 (8.86) |
26.75% | Details | |
| 11/10/2021 | OncoCyte Corp | OCX | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2021 | Cue Health Inc | HLTH | New Coverage | Buy (N/A) |
9.95 (0.29) |
-97.09% | Details | |
| 8/31/2021 | Talis Biomedical Corp. | TLIS | Downgrade | Neutral (Buy) |
9.06 (4.38) |
-51.66% | Details |
